Skip to main content

Applications are invited for Project Associate at NIBMG

Post Graduate Degree in Natural Sciences or bachelors degree in engineering or technology or medicine
Openings for Research Scientist, Senior Project Assistant, Technical Support at AIIMS
Openings for Research Scientist, Senior Project Assistant, Technical Support at AIIMS
First Class Post Graduate Degree in Microbiology or Biotechnology including the integrated PG degrees Or Second Class Post Graduate Degree in Microbiology or Biotechnology, including the integrated PG degree with PhD in Microbiology 
Advertisement for MSc. in Chemistry at CSMCRI
Advertisement for MSc. in Chemistry at CSMCRI
MSc. with a specialization in Organic Chemistry and sound knowledge in organic synthesis
Walk In Interview for PhD Program at NIAB
Walk In Interview for PhD Program at NIAB
Masters degree M.Sc, M.Tech, M.Pharm. or MBBS or B.Tech. degree in any branch of Life Sciences
InStem invites applications for Project Associate Post
InStem invites applications for Project Associate Post
The Institute for Stem Cell Science and Regenerative Medicine is an autonomous institute under the Department of Biotechnology, Ministry of Science
Gland Pharma Inviting Production Experienced Professionals - M.Pharm, B.Pharm, MSc Apply
Gland Pharma Inviting Production Experienced Professionals - M.Pharm, B.Pharm, MSc Apply
B.Sc./ B. Pharmacy /M.Sc. M. Pharmacy; Production Sterile Injectables
Torrent Pharma Walk in Drive for M.Pharm, B.Pharm, MSc in QC, Packing, Production
Torrent Pharma Walk in Drive for M.Pharm, B.Pharm, MSc in QC, Packing, Production
M.Pharm, B.Pharm, M.Sc; Torrent Pharma, the flagship Company of Torrent Group is one of the leading pharma companies
Walk In Interview for M.Pharm, B.Pharm, MSc in Production at Centaur Pharma
Walk In Interview for M.Pharm, B.Pharm, MSc in Production at Centaur Pharma
M.Pharm, B.Pharm, M.Sc, B.Sc; To keep pace with our growth plan, we require young and energetic professionals for our Pune site.
4th Edition Drug Safety Symposium 2025 – India Chapter
4th Edition Drug Safety Symposium 2025 – India Chapter
With patient safety becoming more critical than ever in today's evolving healthcare landscape, the demand for robust drug safety practices continues to surge.
Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001
Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001
Ichnos Glenmark Innovation (IGI), a global, fully integrated clinical- stage biotechnology company focused on developing multispecificsTM in oncology, today presented promising full dose-escalation results from its Phase 1 TRIgnite-1 study of ISB 2001